发明公开
EP3149017A2 NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF CANCER
审中-公开
NUKLEOSIDDERIVATE ZUR BEHANDLUNG VON KREBS
- 专利标题： NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF CANCER
- 专利标题（中）： NUKLEOSIDDERIVATE ZUR BEHANDLUNG VON KREBS
-
申请号： EP15770630.0申请日： 2015-05-27
-
公开(公告)号： EP3149017A2公开(公告)日： 2017-04-05
- 发明人: DOUSSON, Cyril , DUKHAN, David , PARSY, Christophe Claude , ALEXANDRE, François-René , RAHALI, Rachid , PAPARIN, Jean-Laurent
- 申请人： Idenix Pharmaceuticals LLC
- 申请人地址： 320 Bent Street Cambridge, MA 02141 US
- 专利权人： Idenix Pharmaceuticals LLC
- 当前专利权人： Idenix Pharmaceuticals LLC
- 当前专利权人地址： 320 Bent Street Cambridge, MA 02141 US
- 代理机构： Jaap, David Robert
- 优先权： US201462004066P 20140528
- 国际公布： WO2015181624 20151203
- 主分类号： C07H19/10
- IPC分类号： C07H19/10 ; C07H19/11 ; C07H19/20 ; C07H19/213 ; A61K31/7068 ; A61K31/7076 ; A61P35/02
摘要：
Provided herein are compounds, compositions, and methods for the treatment of cancer, including leukemia. In one embodiment, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-cancer agents.
公开/授权文献
- EP3149017B1 NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF CANCER 公开/授权日：2019-12-11
信息查询
IPC分类:
